Abstract
Purpose of Review
In this review, we summarize the recent literature regarding the incidence and treatment of seizures arising after ischemic and hemorrhagic strokes. Additionally, we identify open questions in guidelines and standard clinical care to aid future studies aiming to improve management of seizures in post-stroke patients.
Recent Findings
Studies demonstrate an increasing prevalence of seizures following strokes, probably a consequence of advances in post-stroke management and expanding use of continuous EEG monitoring. Post-stroke seizures are associated with longer hospitalization and increased mortality; therefore, prevention and timely treatment of seizures are important. The standard of care is to treat recurrent seizures with anti-epileptic drugs (AEDs) regardless of the etiology. However, there are no established guidelines currently for prophylactic use of AEDs following a stroke.
Summary
The prevalence of post-stroke seizures is increasing. Further studies are needed to determine the risk factors for recurrent seizures and epilepsy after strokes and optimal treatment strategies.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Sander JW. The epidemiology of epilepsy revisited. Curr Opin Neurol. 2003;16:165–70.
Hauser WA, Beghi E. First seizure definitions and worldwide incidence and mortality. Epilepsia. 2008;49(Suppl 1):8–12.
•• Feyissa AM, Hasan TF, Meschia JF. Stroke-related epilepsy. Eur J Neurol. 2019;26:18–e3 A recent paper which discusses epidemiology, risk factors, presentations, mechanisms, and management of stroke-related epilepsy.
Hasan TF, Rabinstein AA, Middlebrooks EH, Haranhalli N, Silliman SL, Meschia JF, et al. Diagnosis and management of acute ischemic stroke. Mayo Clin Proc. 2018;93:523–38.
Krueger H, Koot J, Hall RE, O’Callaghan C, Bayley M, Corbett D. Prevalence of individuals experiencing the effects of stroke in Canada: trends and projections. Stroke. 2015;46:2226–31.
Silverman IE, Restrepo L, Mathews GC. Poststroke seizures. Arch Neurol. 2002;59:195–201.
• Zou S, Wu X, Zhu B, Yu J, Yang B, Shi J. The pooled incidence of post-stroke seizure in 102 008 patients. Top Stroke Rehabil. 2015;22:460–7 A large meta-analysis on the pooled incidence of post-stroke seizures.
•• Wang JZ, Vyas MV, Saposnik G, Burneo JG. Incidence and management of seizures after ischemic stroke: systematic review and meta-analysis. Neurology. 2017;89:1220–8 A large meta-analysis of the incidence of early and later post-ischemic stroke seizures and pharmacologic treatment.
Zhang C, Wang X, Wang Y, Zhang J, Hu W, Ge M, et al. Risk factors for post-stroke seizures: a systematic review and meta-analysis. Epilepsy Res. 2014;108:1806–16.
• Burneo JG, Fang J, Saposnik G, Investigators of the Registry of the Canadian Stroke Network. Impact of seizures on morbidity and mortality after stroke: a Canadian multi-centre cohort study. Eur J Neurol. 2010;17:52–8 This paper shows an increased resource utilization, length of hospital stay, and decreased 30-day and 1-year survival associated with the presence of seizures following a stroke.
Huang C-W, Saposnik G, Fang J, Steven DA, Burneo JG. Influence of seizures on stroke outcomes: a large multicenter study. Neurology. 2014;82:768–76.
England MJ, Liverman CT, Schultz AM, Strawbridge LM. Epilepsy across the spectrum: promoting health and understanding. A summary of the Institute of Medicine report. Epilepsy Behav. 2012;25:266–76.
•• Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, et al. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016;47:e98–169 Provides a concise synopsis of clinical practices in rehabilitative care of adults recovering from stroke.
Messé SR, Sansing LH, Cucchiara BL, Herman ST, Lyden PD, Kasner SE, et al. Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care. 2009;11:38–44.
Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–37.
• Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Coté R, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57:1617–22 A large international, multicenter, prospective cohort study concluding that seizures are more common following a hemorrhagic stroke than ischemic.
Lambrakis CC, Lancman ME. The phenomenology of seizures and epilepsy after stroke. J Epilepsy. 1998;11:233–40.
Ebersole J. Cortical generators and EEG voltage fields. Curr Pract Clin Electroencephalogr. 4th Revis ed. Alphen aan den Rijn: Wolters Kluwer; 2014. p. 28–44.
Courville CB. Etiology and pathogenesis of laminar cortical necrosis; its significance in evaluation of uniform cortical atrophies of early life. AMA Arch Neurol Psychiatry. 1958;79:7–30.
Hartings JA, Williams AJ, Tortella FC. Occurrence of nonconvulsive seizures, periodic epileptiform discharges, and intermittent rhythmic delta activity in rat focal ischemia. Exp Neurol. 2003;179:139–49.
Sundt TM, Sharbrough FW, Piepgras DG, Kearns TP, Messick JM, O’Fallon WM. Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc. 1981;56:533–43.
Beghi E, D’Alessandro R, Beretta S, Consoli D, Crespi V, Delaj L, et al. Incidence and predictors of acute symptomatic seizures after stroke. Neurology. 2011;77:1785–93.
Browne TR, Holmes GL. Epilepsy. N Engl J Med. 2001;344:1145–51.
Pande SD, Lwin MT, Kyaw KM, Khine AA, Thant AA, Win MM, et al. Post-stroke seizure-do the locations, types and managements of stroke matter? Epilepsia Open. 2018;3:392–8.
Keller L, Hobohm C, Zeynalova S, Classen J, Baum P. Does treatment with t-PA increase the risk of developing epilepsy after stroke? J Neurol. 2015;262:2364–72.
Ferlazzo E, Gasparini S, Beghi E, Sueri C, Russo E, Leo A, et al. Epilepsy in cerebrovascular diseases: review of experimental and clinical data with meta-analysis of risk factors. Epilepsia. 2016;57:1205–14.
• Lahti A-M, Saloheimo P, Huhtakangas J, Salminen H, Juvela S, Bode MK, et al. Poststroke epilepsy in long-term survivors of primary intracerebral hemorrhage. Neurology. 2017;88:2169–75 A recent article identifying the incidence and predisposing factors for the development of epilepsy following primary intracerebral hemorrhage during long-term follow-up.
• Maciel CB, Gilmore EJ. Seizures and epileptiform patterns in SAH and their relation to outcomes. J Clin Neurophysiol. 2016;33:183–95 A review article summarizing the incidence and risk factors for developing seizures and epilepsy following SAH and their relevance to patient outcomes.
Allen BB, Forgacs PB, Fakhar MA, Wu X, Gerber LM, Boddu S, et al. Association of seizure occurrence with aneurysm treatment modality in aneurysmal subarachnoid hemorrhage patients. Neurocrit Care. 2018;29:62–8.
Chan L, Hu C-J, Fan Y-C, Li F-Y, Hu H-H, Hong C-T, et al. Incidence of poststroke seizures: a meta-analysis. J Clin Neurosci. 2018;47:347–51.
Choi K-S, Chun H-J, Yi H-J, Ko Y, Kim Y-S, Kim J-M. Seizures and epilepsy following aneurysmal subarachnoid hemorrhage : incidence and risk factors. J Korean Neurosurg Soc. 2009;46:93–8.
Hesdorffer DC, Benn EKT, Cascino GD, Hauser WA. Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure. Epilepsia. 2009;50:1102–8.
Sung CY, Chu NS. Epileptic seizures in intracerebral haemorrhage. J Neurol Neurosurg Psychiatry. 1989;52:1273–6.
Neshige S, Kuriyama M, Yoshimoto T, Takeshima S, Himeno T, Takamatsu K, et al. Seizures after intracerebral hemorrhage; risk factor, recurrence, efficacy of antiepileptic drug. J Neurol Sci. 2015;359:318–22.
Rumbach L, Sablot D, Berger E, Tatu L, Vuillier F, Moulin T. Status epilepticus in stroke: report on a hospital-based stroke cohort. Neurology. 2000;54:350–4.
• De Marchis GM, Pugin D, Meyers E, Velasquez A, Suwatcharangkoon S, Park S, et al. Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome. Neurology. 2016;86:253–60 This study found that seizure burden was associated with a worsening functional outcome and cognitive impairment 3 months after SAH.
Belcastro V, Vidale S, Gorgone G, Pisani LR, Sironi L, Arnaboldi M, et al. Non-convulsive status epilepticus after ischemic stroke: a hospital-based stroke cohort study. J Neurol. 2014;261:2136–42.
• Naidech AM, Beaumont J, Muldoon K, Liotta EM, Maas MB, Potts MB, et al. Prophylactic seizure medication and health-related quality of life after intracerebral hemorrhage. Crit Care Med. 2018;46:1480–5 This article measures cognitive function and health-related quality of life associated with prophylactic levetiracetam following intracerebral hemorrhage.
Chung JM. Seizures in the acute stroke setting. Neurol Res. 2014;36:403–6.
•• Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475–82 A paper revising the definition of epilepsy.
Hauser WA, Rich SS, Annegers JF, Anderson VE. Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology. 1990;40:1163–70.
Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke. 2004;35:1769–75.
Leung T, Leung H, Soo YOY, Mok VCT, Wong KS. The prognosis of acute symptomatic seizures after ischaemic stroke. J Neurol Neurosurg Psychiatry. 2017;88:86–94.
Fox CK, Glass HC, Sidney S, Lowenstein DH, Fullerton HJ. Acute seizures predict epilepsy after childhood stroke. Ann Neurol. 2013;74:249–56.
Sung CY, Chu NS. Epileptic seizures in thrombotic stroke. J Neurol. 1990;237:166–70.
Towne AR, Waterhouse EJ, Boggs JG, Garnett LK, Brown AJ, Smith JR, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology. 2000;54:340–5.
• Elmer J, Rittenberger JC, Faro J, Molyneaux BJ, Popescu A, Callaway CW, et al. Clinically distinct electroencephalographic phenotypes of early myoclonus after cardiac arrest. Ann Neurol. 2016;80:175–84 This paper classifies EEG phenotypes of early post-anoxic multifocal myoclonus that develop after cardiac arrest.
• Wolf ME, Ebert AD, Chatzikonstantinou A. The use of routine EEG in acute ischemic stroke patients without seizures: generalized but not focal EEG pathology is associated with clinical deterioration. Int J Neurosci. 2017;127:421–6 This paper focuses on the importance of EEG and findings after a stroke and prediction of post-stroke epilepsy.
Bentes C, Martins H, Peralta AR, Morgado C, Casimiro C, Franco AC, et al. Early EEG predicts poststroke epilepsy. Epilepsia Open. 2018;3:203–12.
• Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62:1743–8 Reveals the frequency of non-convulsive seizures and the importance of EEG in critically ill patients with suspected non-convulsive seizures.
Pandian JD, Cascino GD, So EL, Manno E, Fulgham JR. Digital video-electroencephalographic monitoring in the neurological-neurosurgical intensive care unit: clinical features and outcome. Arch Neurol. 2004;61:1090–4.
Broderick JP, Adams HP, Barsan W, Feinberg W, Feldmann E, Grotta J, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1999;30:905–15.
Naidech AM, Garg RK, Liebling S, Levasseur K, Macken MP, Schuele SU, et al. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke. 2009;40:3810–5.
Tartara A, Galimberti CA, Manni R, Parietti L, Zucca C, Baasch H, et al. Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients. Br J Clin Pharmacol. 1991;32:335–40.
Temkin NR, Dikmen SS, Anderson GD, Wilensky AJ, Holmes MD, Cohen W, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg. 1999;91:593–600.
Troisi E, Paolucci S, Silvestrini M, Matteis M, Vernieri F, Grasso MG, et al. Prognostic factors in stroke rehabilitation: the possible role of pharmacological treatment. Acta Neurol Scand. 2002;105:100–6.
•• Morgenstern LB, Hemphill JC, Anderson C, Becker K, Broderick JP, Connolly ES, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–29 The most recent AHA guideline and recommendations for prophylaxis and management of seizures following an intracerebral hemorrhage.
•• Holtkamp M, Beghi E, Benninger F, Kälviäinen R, Rocamora R, Christensen H. European Stroke Organisation guidelines for the management of post-stroke seizures and epilepsy. Eur Stroke J. 2017;2:103–15 The most recent European guideline and recommendations regarding management of post-stroke seizures and epilepsy.
Stepień K, Tomaszewski M, Czuczwar SJ. Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs--an update. Pharmacol Rep. 2005;57:719–33.
Shetty AK. Prospects of levetiracetam as a neuroprotective drug against status epilepticus, traumatic brain injury, and stroke. Front Neurol. 2013;4:172.
Semah F, Picot MC, Adam C, Broglin D, Arzimanoglou A, Bazin B, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 1998;51:1256–62.
Gasparini S, Ferlazzo E, Beghi E, Sofia V, Mumoli L, Labate A, et al. Epilepsy associated with leukoaraiosis mainly affects temporal lobe: a casual or causal relationship? Epilepsy Res. 2015;109:1–8.
Belcastro V, Vidale S, Pierguidi L, Sironi L, Tancredi L, Striano P, et al. Intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly: a proof-of-concept, observational study. Seizure. 2013;22:905–7.
Naylor J, Thevathasan A, Churilov L, Guo R, Xiong Y, Koome M, et al. Association between different acute stroke therapies and development of post stroke seizures. BMC Neurol. 2018;18:61.
Alvarez V, Rossetti AO, Papavasileiou V, Michel P. Acute seizures in acute ischemic stroke: does thrombolysis have a role to play? J Neurol. 2013;260:55–61.
Bentes C, Martins H, Peralta AR, Morgado C, Casimiro C, Franco AC, et al. Epileptic manifestations in stroke patients treated with intravenous alteplase. Eur J Neurol. 2017;24:755–61.
Tan M-L, Ng A, Pandher PS, Sashindranath M, Hamilton JA, Davis SM, et al. Tissue plasminogen activator does not alter development of acquired epilepsy. Epilepsia. 2012;53:1998–2004.
Etminan M, Samii A, Brophy JM. Statin use and risk of epilepsy: a nested case-control study. Neurology. 2010;75:1496–500.
Guo J, Guo J, Li J, Zhou M, Qin F, Zhang S, et al. Statin treatment reduces the risk of poststroke seizures. Neurology. 2015;85:701–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Joseph W. Doria and Peter B. Forgacs each declares no potential conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Epilepsy
Rights and permissions
About this article
Cite this article
Doria, J.W., Forgacs, P.B. Incidence, Implications, and Management of Seizures Following Ischemic and Hemorrhagic Stroke. Curr Neurol Neurosci Rep 19, 37 (2019). https://doi.org/10.1007/s11910-019-0957-4
Published:
DOI: https://doi.org/10.1007/s11910-019-0957-4